With the acquisition, Mountain View, Calif.-based Livongo Health said it will make Retrofit’s Diabetes Prevention program available as Livongo DPP, powered by Retrofit. Livongo said the acquisition acts as a compliment to its Livongo for Diabetes and Livongo for Hypertension programs.
“Retrofit has built strong, evidence-based, offerings in weight management and disease prevention and brings a great group of committed people. We’re excited to welcome their team into the Livongo family. For our members, we now have more services that make it easier to prevent individuals from getting sick and, if they do, working with them to return to health and stay healthy. And for our clients, we’re now addressing the comprehensive health challenges their employees face, with the goal of caring for each as a whole person,” Livongo CEO Glen Tullman said in a prepared statement.
Livongo said it will also make use of Retrofit’s over seven years of data insights, coaches and proprietary lifestyle factor segmentation to improve its personalized offerings. Retrofit CEO Mary Pigatti will join Livongo as part of the acquisition, and will remain at the head of Retrofit.
“Retrofit and Livongo are like-minded in strategy, values and culture. Together, we will provide a comprehensive set of solutions for the prevention and treatment of chronic conditions that address the whole person. This move strengthens our ability to bring personalized solutions to our clients and members,” Retrofit CEO Pigatti said in a press release.
Last week, Livongo closed a $105 million round led by a group of investors including General Catalyst, Merck Global Health Innovation Fund and Echo Health Ventures.